Shintani S - Search Results

1

General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: Effects on the central nervous system.

Shintani S, Toba Y, Suzuki S, Ninomiya S, Umezato M, Hiyama T. Shintani S, et al. Arzneimittelforschung. 1985;35(7A):1157-62. Arzneimittelforschung. 1985. PMID: 4074429

2

General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.

Shintani S, Watanabe K, Kawamura K, Mori T, Tani T, Toba Y, Sasabe H, Nakagiri N, Hongoh O, Fujita S, et al. Shintani S, et al. Arzneimittelforschung. 1985;35(7A):1163-72. Arzneimittelforschung. 1985. PMID: 3000392

3

General pharmacological properties of the main metabolite of flosequinan.

Fujita S, Ikezono K, Umezato M, Hosoki E, Toba Y, Ishikawa M, Kusunoki A, Shintani S. Fujita S, et al. Among authors: shintani s. Arzneimittelforschung. 1992 Oct;42(10):1212-22. Arzneimittelforschung. 1992. PMID: 1335257

4

General pharmacological properties of the new vasodilator flosequinan.

Ikezono K, Fujita S, Umezato M, Hosoki E, Toba Y, Kusunoki A, Shintani S. Ikezono K, et al. Among authors: shintani s. Arzneimittelforschung. 1992 Oct;42(10):1200-11. Arzneimittelforschung. 1992. PMID: 1472141

5

[Pharmacological properties of buprenorphine, a new analgesic agent. Part II. (author's transl)].

Shintani S, Umezato M, Toba Y, Yamaji Y, Kitaura K, Tani T, Ishiyama H, Kikuchi T, Mori T, Nakai S, Watanabe K, Hiyama T. Shintani S, et al. Nihon Yakurigaku Zasshi. 1982 Mar;79(3):173-91. doi: 10.1254/fpj.79.173. Nihon Yakurigaku Zasshi. 1982. PMID: 6123475 Japanese.

6

[Pharmacological properties of procaterol, a newly synthetized, specific beta 2-adrenoceptor stimulant. Part I. Effects on the CNS (author's transl)].

Hashimoto K, Shintani S, Yamashita S, Tei S, Takai M, Tsutsui M, Kawamura K, Ohkawa T, Hiyama T, Yabuuchi Y. Hashimoto K, et al. Among authors: shintani s. Nihon Yakurigaku Zasshi. 1979 Apr 20;75(3):271-89. Nihon Yakurigaku Zasshi. 1979. PMID: 43821 Japanese.

7

[Analgesic and narcotic antagonist effects of buprenorphine (author's transl)].

Hiyama T, Shintani S, Tsutsui M, Yasuda Y. Hiyama T, et al. Among authors: shintani s. Nihon Yakurigaku Zasshi. 1982 Mar;79(3):147-62. Nihon Yakurigaku Zasshi. 1982. PMID: 7084817 Japanese.

8

[Pharmacological properties of procaterol, a newly synthesized, specific beta 2-adrenoceptor stimulant. Part II. Effects on the peripheral organs (author's transl)].

Hashimoto K, Shintani S, Yamashita S, Tei S, Takai M, Tsutsui M, Kawamura K, Ohkawa T, Hiyama T, Yabuuchi Y. Hashimoto K, et al. Among authors: shintani s. Nihon Yakurigaku Zasshi. 1979 May;75(4):333-64. Nihon Yakurigaku Zasshi. 1979. PMID: 43822 Japanese.

9

[Interactions between buprenorphine, narcotic analgesic, and centrally acting drugs in prolongation of halothane-induced sleeping and analgesia (author's transl)].

Yasuda Y, Shioya Y, Nakai S, Shintani S, Hiyama T. Yasuda Y, et al. Among authors: shintani s. Nihon Yakurigaku Zasshi. 1982 Mar;79(3):163-72. Nihon Yakurigaku Zasshi. 1982. PMID: 6123474 Japanese.

10

The effects of amylin on insulin secretion from Rin m5F cells and glycogen synthesis and lipogenesis in rat primary cultured hepatocytes.

Suzuki S, Murakami M, Abe S, Satoh Y, Shintani S, Ishizuka J, Suzuki K, Thompson JC, Toyota T. Suzuki S, et al. Among authors: shintani s. Diabetes Res Clin Pract. 1992 Jan;15(1):77-84. doi: 10.1016/0168-8227(92)90071-x. Diabetes Res Clin Pract. 1992. PMID: 1311671

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

428 results

Search Page

Filters